The word of the moment is "new!" We have a new year, a new president, we are looking at the possibility of another new organizational structure in medicine, and we are working on a new look here at Dermatology Times.
Dr. Norman Levine muses on an alternate universe in which he makes the rules for anything related to the dermatology specialty. After reading, he notes many may be relieved that he will never rule the (dermatology) world. But are changes necessary? You tell us.
The New Year is a time during which most of us celebrate the idea of fresh starts. It’s also a time of reflection. In the spirit of this New Year, Dermatology Times asked several top dermatologists to ponder their legacies.
Corporations wish to grow and get bigger until finances intervene and then sometimes split or spin off children in the form of smaller corporations. Now corporations have overtaken medicine. What does this mean for the physician?
We utilize numerous medications in dermatology where potentially severe side effects can occur and can be detected by laboratory analysis. However, many commonly prescribed drugs rarely cause problems but have acquired the reputation of potentially toxic agents, which require close laboratory monitoring. Although many would disagree me, these are the medications that dermatologists over test.
When routine skin injuries such as mild burns, skin tears, uncomplicated stasis ulcers and minor post-operative wound complications become a routine part of the wound care center purview and are no longer considered a part of what dermatologists can do or wish to do, the dermatology discipline shrinks further toward a marginalized specialty. Learn more
Given the numerous types of honey and geographic variances of bee products and what is known already about honey’s use in skin therapy, it follows that there is likely untapped potential for dermatologic application, and more investigation is clearly warranted.